These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 21856294)
1. 15-Hydroxyprostaglandin dehydrogenase as a novel molecular target for cancer chemoprevention and therapy. Na HK; Park JM; Lee HG; Lee HN; Myung SJ; Surh YJ Biochem Pharmacol; 2011 Nov; 82(10):1352-60. PubMed ID: 21856294 [TBL] [Abstract][Full Text] [Related]
2. Prostaglandin catabolic enzymes as tumor suppressors. Tai HH Cancer Metastasis Rev; 2011 Dec; 30(3-4):409-17. PubMed ID: 22020925 [TBL] [Abstract][Full Text] [Related]
3. 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer. Wolf I; O'Kelly J; Rubinek T; Tong M; Nguyen A; Lin BT; Tai HH; Karlan BY; Koeffler HP Cancer Res; 2006 Aug; 66(15):7818-23. PubMed ID: 16885386 [TBL] [Abstract][Full Text] [Related]
4. HGF/Met signalling promotes PGE(2) biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells. Moore AE; Greenhough A; Roberts HR; Hicks DJ; Patsos HA; Williams AC; Paraskeva C Carcinogenesis; 2009 Oct; 30(10):1796-804. PubMed ID: 19638428 [TBL] [Abstract][Full Text] [Related]
5. Regulation of 15-hydroxyprostaglandin dehydrogenase expression in hepatocellular carcinoma. Castro-Sánchez L; Agra N; Llorente Izquierdo C; Motiño O; Casado M; Boscá L; Martín-Sanz P Int J Biochem Cell Biol; 2013 Nov; 45(11):2501-11. PubMed ID: 23954207 [TBL] [Abstract][Full Text] [Related]
6. 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer. Thiel A; Ganesan A; Mrena J; Junnila S; Nykänen A; Hemmes A; Tai HH; Monni O; Kokkola A; Haglund C; Petrova TV; Ristimäki A Clin Cancer Res; 2009 Jul; 15(14):4572-80. PubMed ID: 19584167 [TBL] [Abstract][Full Text] [Related]
7. NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer. Ding Y; Tong M; Liu S; Moscow JA; Tai HH Carcinogenesis; 2005 Jan; 26(1):65-72. PubMed ID: 15358636 [TBL] [Abstract][Full Text] [Related]
8. 15-Hydroxyprostaglandin-dehydrogenase is involved in anti-proliferative effect of non-steroidal anti-inflammatory drugs COX-1 inhibitors on a human medullary thyroid carcinoma cell line. Quidville V; Segond N; Lausson S; Frenkian M; Cohen R; Jullienne A Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):14-30. PubMed ID: 16997128 [TBL] [Abstract][Full Text] [Related]
9. Levels of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase are reduced in inflammatory bowel disease: evidence for involvement of TNF-alpha. Otani T; Yamaguchi K; Scherl E; Du B; Tai HH; Greifer M; Petrovic L; Daikoku T; Dey SK; Subbaramaiah K; Dannenberg AJ Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G361-8. PubMed ID: 16195422 [TBL] [Abstract][Full Text] [Related]
10. 15-Deoxy-Δ12,14-prostaglandin J2 induces expression of 15-hydroxyprostaglandin dehydrogenase through Elk-1 activation in human breast cancer MDA-MB-231 cells. Kim HR; Lee HN; Lim K; Surh YJ; Na HK Mutat Res; 2014 Oct; 768():6-15. PubMed ID: 25773924 [TBL] [Abstract][Full Text] [Related]
11. Renal localization and regulation of 15-hydroxyprostaglandin dehydrogenase. Yao B; Xu J; Harris RC; Zhang MZ Am J Physiol Renal Physiol; 2008 Feb; 294(2):F433-9. PubMed ID: 18057186 [TBL] [Abstract][Full Text] [Related]
12. Experimental cancer therapy using restoration of NAD+ -linked 15-hydroxyprostaglandin dehydrogenase expression. Kaliberova LN; Kusmartsev SA; Krendelchtchikova V; Stockard CR; Grizzle WE; Buchsbaum DJ; Kaliberov SA Mol Cancer Ther; 2009 Nov; 8(11):3130-9. PubMed ID: 19887544 [TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal anti-inflammatory drugs suppress glioma via 15-hydroxyprostaglandin dehydrogenase. Wakimoto N; Wolf I; Yin D; O'Kelly J; Akagi T; Abramovitz L; Black KL; Tai HH; Koeffler HP Cancer Res; 2008 Sep; 68(17):6978-86. PubMed ID: 18757412 [TBL] [Abstract][Full Text] [Related]
14. Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells. Tong M; Ding Y; Tai HH Carcinogenesis; 2006 Nov; 27(11):2170-9. PubMed ID: 16632868 [TBL] [Abstract][Full Text] [Related]
15. Hemokinin-1 stimulates prostaglandin E₂ production in human colon through activation of cyclooxygenase-2 and inhibition of 15-hydroxyprostaglandin dehydrogenase. Dai L; Perera DS; King DW; Southwell BR; Burcher E; Liu L J Pharmacol Exp Ther; 2012 Jan; 340(1):27-36. PubMed ID: 21957267 [TBL] [Abstract][Full Text] [Related]
16. 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is up-regulated by flurbiprofen and other non-steroidal anti-inflammatory drugs in human colon cancer HT29 cells. Chi X; Freeman BM; Tong M; Zhao Y; Tai HH Arch Biochem Biophys; 2009 Jul; 487(2):139-45. PubMed ID: 19501039 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by cyclooxygenase inhibitors and chemopreventive agents. Cho H; Tai HH Prostaglandins Leukot Essent Fatty Acids; 2002 Dec; 67(6):461-5. PubMed ID: 12468268 [TBL] [Abstract][Full Text] [Related]
18. A potential anti-tumor effect of leukotriene C4 through the induction of 15-hydroxyprostaglandin dehydrogenase expression in colon cancer cells. Mehdawi LM; Satapathy SR; Gustafsson A; Lundholm K; Alvarado-Kristensson M; Sjölander A Oncotarget; 2017 May; 8(21):35033-35047. PubMed ID: 28402256 [TBL] [Abstract][Full Text] [Related]